Suppr超能文献

一种基于拓扑学的方法,用于减轻保乳放疗中瘤床补量体积位置变化所导致的剂量学不确定性。

A topology-based method to mitigate the dosimetric uncertainty caused by the positional variation of the boost volume in breast conservative radiotherapy.

作者信息

Lee Peng-Yi, Lin Chih-Yuan, Chen Shang-Wen, Chien Chun-Ru, Chu Chun-Nan, Hsu Hsiu-Ting, Liang Ji-An, Lin Ying-Jun, Shiau An-Cheng

机构信息

Department of Radiation Oncology, China Medical University Hospital, 2nd Yu-De Road, North District, Taichung City, Taiwan.

Department of Medicine, China Medical University, Taichung, Taiwan.

出版信息

Radiat Oncol. 2017 Mar 20;12(1):55. doi: 10.1186/s13014-017-0801-4.

Abstract

BACKGROUND

To improve local control rate in patients with breast cancer receiving adjuvant radiotherapy after breast conservative surgery, additional boost dose to the tumor bed could be delivered simultaneously via the simultaneous integrated boost (SIB) modulated technique. However, the position of tumor bed kept changing during the treatment course as the treatment position was aligned to bony anatomy. This study aimed to analyze the positional uncertainties between bony anatomy and tumor bed, and a topology-based approach was derived to stratify patients with high variation in tumor bed localization.

METHODS

Sixty patients with early-stage breast cancer or ductal carcinoma in situ were enrolled. All received adjuvant whole breast radiotherapy with or without local boost via SIB technique. The delineation of tumor bed was defined by incorporating the anatomy of seroma, adjacent surgical clips, and any architectural distortion on computed tomography simulation. A total of 1740 on-board images were retrospectively analyzed. Positional uncertainty of tumor bed was assessed by four components: namely systematic error (SE), and random error (RE), through anterior-posterior (AP), cranial-caudal (CC), left-right (LR) directions and couch rotation (CR). Age, tumor location, and body-mass factors including volume of breast, volume of tumor bed, breast thickness, and body mass index (BMI) were analyzed for their predictive role. The appropriate margin to accommodate the positional uncertainty of the boost volume was assessed, and the new plans with this margin for the tumor bed was designed as the high risk planning target volume (PTV-H) were created retrospectively to evaluate the impact on organs at risk.

RESULTS

In univariate analysis, a larger breast thickness, larger breast volume, higher BMI, and different tumor locations correlated with a greater positional uncertainty of tumor bed. However, BMI was the only factor associated with displacements of surgical clips in the multivariate analysis and patients with higher BMI were stratified as high variation group. When image guidance was aligned to bony structures, the SE and RE of clip displacement were consistently larger in the high variation group. The corresponding PTV-H margins for the high- and low-variation groups were 7, 10, 10 mm and 4, 9, 6 mm in AP, CC, LR directions, respectively. The heart dose between the two plans was not significantly different, whereas the dosimetric parameters for the ipsilateral lung were generally higher in the new plans.

CONCLUSIONS

In patients with breast cancer receiving adjuvant radiotherapy, a higher BMI is associated with a greater positional uncertainty of the boost tumor volume. More generous margin should be considered and it can be safely applied through proper design of beam arrangement with advanced treatment techniques.

摘要

背景

为提高保乳手术后接受辅助放疗的乳腺癌患者的局部控制率,可通过同步整合加量(SIB)调制技术同时向瘤床给予额外的加量剂量。然而,在治疗过程中,随着治疗体位与骨骼解剖结构对齐,瘤床位置不断变化。本研究旨在分析骨骼解剖结构与瘤床之间的位置不确定性,并推导一种基于拓扑学的方法对瘤床定位变化较大的患者进行分层。

方法

纳入60例早期乳腺癌或导管原位癌患者。所有患者均接受辅助全乳放疗,部分患者通过SIB技术进行局部加量。瘤床的勾画通过结合血清肿的解剖结构、相邻手术夹以及计算机断层扫描模拟上的任何结构变形来定义。回顾性分析了总共1740张机载图像。通过前后(AP)、头脚(CC)、左右(LR)方向以及治疗床旋转(CR)四个分量评估瘤床的位置不确定性,包括系统误差(SE)和随机误差(RE)。分析年龄、肿瘤位置以及身体质量因素(包括乳房体积、瘤床体积、乳房厚度和体重指数(BMI))的预测作用。评估容纳加量体积位置不确定性的合适边界,并回顾性创建具有该边界的瘤床新计划作为高风险计划靶区(PTV-H),以评估对危及器官的影响。

结果

单因素分析中,乳房厚度较大、乳房体积较大、BMI较高以及不同的肿瘤位置与瘤床更大的位置不确定性相关。然而,在多因素分析中,BMI是与手术夹移位相关的唯一因素,BMI较高的患者被分层为高变异组。当图像引导与骨骼结构对齐时,高变异组中手术夹移位的SE和RE始终更大。高变异组和低变异组在AP、CC、LR方向上相应的PTV-H边界分别为7、10、10毫米和4、9、6毫米。两个计划之间心脏剂量无显著差异,而新计划中同侧肺的剂量学参数通常更高。

结论

在接受辅助放疗的乳腺癌患者中,较高的BMI与加量肿瘤体积更大的位置不确定性相关。应考虑更宽的边界,并且通过采用先进治疗技术合理设计射束排列可以安全应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee4e/5359879/01e5baefd882/13014_2017_801_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验